source
- Experts warn of safety risks as FDA targets compounded GLP-1 weight-loss drugs sold by telehealth firmsAt the HLTH conference, experts highlighted growing concerns about telehealth companies that sell compounded GLP-1 weight-loss medications. These firms create custom formulations and ship them dir…
- Trump administration withdraws Heidi Overton’s FDA nomination amid Senate support concernsThe Trump administration has pulled the nomination of Heidi Overton to become the U.S. Food and Drug Administration commissioner, saying she lacked sufficient backing to win Senate confirmation. T…